Market closedNon-fractional
Eli Lilly/LLY
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Eli Lilly
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
Ticker
LLY
Sector
Healthcare
Trading on
NYSE
Industry
Pharmaceuticals
Headquarters
Indianapolis, United States
Employees
43,000
Website
www.lilly.com
Eli Lilly Metrics
BasicAdvanced
$739B
Market cap
120.93
P/E ratio
$6.79
EPS
0.41
Beta
$4.69
Dividend rate
0.57%
Dividend yield
Price and volume
Market cap
$739B
Beta
0.41
Dividend rate
$4.69
Financial strength
Current ratio
1.354
Quick ratio
0.674
Long term debt to equity
191.352
Total debt to equity
204.278
Dividend payout ratio (TTM)
68.77%
Interest coverage (TTM)
19.98%
Management effectiveness
Return on assets (TTM)
12.73%
Return on equity (TTM)
50.75%
Valuation
Price to earnings (TTM)
120.933
Price to revenue (TTM)
20.558
Price to book
57.74
Price to tangible book (TTM)
666.19
Price to free cash flow (TTM)
-322.356
Dividend yield (TTM)
0.57%
Growth
Revenue change (TTM)
29.76%
Earnings per share change (TTM)
7.97%
3-year revenue growth (CAGR)
12.13%
3-year earnings per share growth (CAGR)
0.55%
3-year dividend per share growth (CAGR)
15.17%
What the Analysts think about Eli Lilly
Analyst Ratings
Majority rating from 29 analysts.
Eli Lilly Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Eli Lilly Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Eli Lilly News
AllArticlesVideos
MORF INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Morphic Holding, Inc. and Encourages Investors to Contact the Firm!
Accesswire·5 hours ago
Pharmaceutical stocks to watch for end of 2024
Finbold·11 hours ago
Watch These Eli Lilly Stock Price Levels as Weight-Loss Drug Competition Rises
Investopedia·13 hours ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
Aug
15
Eli Lilly
Dividend·Ex-dividend
Sept
10
Eli Lilly
Dividend·Payment
$1.30
Per share
FAQs
What’s the current market cap for Eli Lilly stock?
Eli Lilly (LLY) has a market cap of $739B as of July 27, 2024.
What is the P/E ratio for Eli Lilly stock?
The price to earnings (P/E) ratio for Eli Lilly (LLY) stock is 120.93 as of July 27, 2024.
Does Eli Lilly stock pay dividends?
Yes, the Eli Lilly (LLY) stock pays dividends to shareholders. As of July 27, 2024, the dividend rate is $4.69 and the yield is 0.57%. Eli Lilly has a payout ratio of 68.77% on a trailing twelve-month basis.
When is the next Eli Lilly dividend payment date?
The next Eli Lilly (LLY) dividend payment is scheduled for September 10, 2024.
What is the beta indicator for Eli Lilly?
Eli Lilly (LLY) has a beta rating of 0.41. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Eli Lilly stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.